Learning from Both Sides

Experiences and Opportunities in the Investigation of Australian Aboriginal Medicinal Plants

Bradley Simpson, David Claudie, Nicholas Smith, Ross McKinnon, Susan Semple

    Research output: Contribution to journalArticleResearchpeer-review

    1 Downloads (Pure)

    Abstract

    With one of the oldest surviving cultures in the world, Australian Aboriginal people have developed immense knowledge about the diverse Australian flora. Western scientific investigation of some Australian Aboriginal medicinal plants has demonstrated interesting pharmacological activities and chemistry, however the majority of these species have not yet been extensively examined. We argue that research that is locally initiated and driven by Indigenous traditional owners in collaboration with Western scientists has significant potential to develop new plant-based products. Locally driven medicinal plants research in which traditional owners work as researchers in collaboration with University-based colleagues in the investigation of medicines rather than “stakeholders” or “informants” is one model that may be used in characterising plants with the potential to be developed into sustainable plant-based medicinal products with commercial value. Our team has taken this approach in research located both on traditional homelands and in the laboratory. Research being conducted by the University of South Australia and Chuulangun Aboriginal Corporation has led to patent filing for protection of intellectual property associated with novel compounds and extracts with the potential for development through cosmetic, complementary medicine and pharmaceutical routes. Ongoing research is examining the commercial developmental pathways and requirements for product development in these spaces. This review will address the opportunities that might exist for working in partnership with Australian Indigenous communities, some of the scientific knowledge which has been generated so far from our work together and the lessons learnt since the inception of the collaboration between the Chuulangun Aboriginal Corporation and scientists from the University of South Australia.
    Original languageEnglish
    Pages (from-to)259-271
    Number of pages13
    JournalJournal of Pharmacy and Pharmaceutical Sciences
    Volume16
    Issue number2
    DOIs
    Publication statusPublished - 2013

    Fingerprint

    Medicinal Plants
    Learning
    Research
    South Australia
    Intellectual Property
    Complementary Therapies
    Cosmetics
    Research Personnel
    Pharmacology
    Pharmaceutical Preparations

    Cite this

    Simpson, Bradley ; Claudie, David ; Smith, Nicholas ; McKinnon, Ross ; Semple, Susan. / Learning from Both Sides : Experiences and Opportunities in the Investigation of Australian Aboriginal Medicinal Plants. In: Journal of Pharmacy and Pharmaceutical Sciences. 2013 ; Vol. 16, No. 2. pp. 259-271.
    @article{318eb1fdb2d14e329d6151e133e4311c,
    title = "Learning from Both Sides: Experiences and Opportunities in the Investigation of Australian Aboriginal Medicinal Plants",
    abstract = "With one of the oldest surviving cultures in the world, Australian Aboriginal people have developed immense knowledge about the diverse Australian flora. Western scientific investigation of some Australian Aboriginal medicinal plants has demonstrated interesting pharmacological activities and chemistry, however the majority of these species have not yet been extensively examined. We argue that research that is locally initiated and driven by Indigenous traditional owners in collaboration with Western scientists has significant potential to develop new plant-based products. Locally driven medicinal plants research in which traditional owners work as researchers in collaboration with University-based colleagues in the investigation of medicines rather than “stakeholders” or “informants” is one model that may be used in characterising plants with the potential to be developed into sustainable plant-based medicinal products with commercial value. Our team has taken this approach in research located both on traditional homelands and in the laboratory. Research being conducted by the University of South Australia and Chuulangun Aboriginal Corporation has led to patent filing for protection of intellectual property associated with novel compounds and extracts with the potential for development through cosmetic, complementary medicine and pharmaceutical routes. Ongoing research is examining the commercial developmental pathways and requirements for product development in these spaces. This review will address the opportunities that might exist for working in partnership with Australian Indigenous communities, some of the scientific knowledge which has been generated so far from our work together and the lessons learnt since the inception of the collaboration between the Chuulangun Aboriginal Corporation and scientists from the University of South Australia.",
    author = "Bradley Simpson and David Claudie and Nicholas Smith and Ross McKinnon and Susan Semple",
    note = "This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.",
    year = "2013",
    doi = "10.18433/J31S4Q",
    language = "English",
    volume = "16",
    pages = "259--271",
    journal = "Journal of Pharmacy and Pharmaceutical Sciences",
    issn = "1482-1826",
    publisher = "Canadian Society for Pharmaceutical Sciences",
    number = "2",

    }

    Learning from Both Sides : Experiences and Opportunities in the Investigation of Australian Aboriginal Medicinal Plants. / Simpson, Bradley; Claudie, David; Smith, Nicholas; McKinnon, Ross; Semple, Susan.

    In: Journal of Pharmacy and Pharmaceutical Sciences, Vol. 16, No. 2, 2013, p. 259-271.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Learning from Both Sides

    T2 - Experiences and Opportunities in the Investigation of Australian Aboriginal Medicinal Plants

    AU - Simpson, Bradley

    AU - Claudie, David

    AU - Smith, Nicholas

    AU - McKinnon, Ross

    AU - Semple, Susan

    N1 - This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.

    PY - 2013

    Y1 - 2013

    N2 - With one of the oldest surviving cultures in the world, Australian Aboriginal people have developed immense knowledge about the diverse Australian flora. Western scientific investigation of some Australian Aboriginal medicinal plants has demonstrated interesting pharmacological activities and chemistry, however the majority of these species have not yet been extensively examined. We argue that research that is locally initiated and driven by Indigenous traditional owners in collaboration with Western scientists has significant potential to develop new plant-based products. Locally driven medicinal plants research in which traditional owners work as researchers in collaboration with University-based colleagues in the investigation of medicines rather than “stakeholders” or “informants” is one model that may be used in characterising plants with the potential to be developed into sustainable plant-based medicinal products with commercial value. Our team has taken this approach in research located both on traditional homelands and in the laboratory. Research being conducted by the University of South Australia and Chuulangun Aboriginal Corporation has led to patent filing for protection of intellectual property associated with novel compounds and extracts with the potential for development through cosmetic, complementary medicine and pharmaceutical routes. Ongoing research is examining the commercial developmental pathways and requirements for product development in these spaces. This review will address the opportunities that might exist for working in partnership with Australian Indigenous communities, some of the scientific knowledge which has been generated so far from our work together and the lessons learnt since the inception of the collaboration between the Chuulangun Aboriginal Corporation and scientists from the University of South Australia.

    AB - With one of the oldest surviving cultures in the world, Australian Aboriginal people have developed immense knowledge about the diverse Australian flora. Western scientific investigation of some Australian Aboriginal medicinal plants has demonstrated interesting pharmacological activities and chemistry, however the majority of these species have not yet been extensively examined. We argue that research that is locally initiated and driven by Indigenous traditional owners in collaboration with Western scientists has significant potential to develop new plant-based products. Locally driven medicinal plants research in which traditional owners work as researchers in collaboration with University-based colleagues in the investigation of medicines rather than “stakeholders” or “informants” is one model that may be used in characterising plants with the potential to be developed into sustainable plant-based medicinal products with commercial value. Our team has taken this approach in research located both on traditional homelands and in the laboratory. Research being conducted by the University of South Australia and Chuulangun Aboriginal Corporation has led to patent filing for protection of intellectual property associated with novel compounds and extracts with the potential for development through cosmetic, complementary medicine and pharmaceutical routes. Ongoing research is examining the commercial developmental pathways and requirements for product development in these spaces. This review will address the opportunities that might exist for working in partnership with Australian Indigenous communities, some of the scientific knowledge which has been generated so far from our work together and the lessons learnt since the inception of the collaboration between the Chuulangun Aboriginal Corporation and scientists from the University of South Australia.

    U2 - 10.18433/J31S4Q

    DO - 10.18433/J31S4Q

    M3 - Article

    VL - 16

    SP - 259

    EP - 271

    JO - Journal of Pharmacy and Pharmaceutical Sciences

    JF - Journal of Pharmacy and Pharmaceutical Sciences

    SN - 1482-1826

    IS - 2

    ER -